| Survival in patients with primary pulmonary hypertension: results from a national prospective registry GE D'Alonzo, RJ Barst, SM Ayres, EH Bergofsky, BH Brundage, KM Detre, ... Annals of internal medicine 115 (5), 343-349, 1991 | 4629 | 1991 |
| A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension RJ Barst, LJ Rubin, WA Long, MD McGoon, S Rich, DB Badesch, ... New England Journal of Medicine 334 (5), 296-301, 1996 | 3406 | 1996 |
| Primary pulmonary hypertension: a national prospective study S Rich, DR Dantzker, SM Ayres, EH Bergofsky, BH Brundage, KM Detre, ... Annals of internal medicine 107 (2), 216-223, 1987 | 2869 | 1987 |
| Clinical classification of pulmonary hypertension G Simonneau, N Galiè, LJ Rubin, D Langleben, W Seeger, ... Journal of the American College of Cardiology 43 (12S), S5-S12, 2004 | 2717 | 2004 |
| The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension S Rich, E Kaufmann, PS Levy New England Journal of Medicine 327 (2), 76-81, 1992 | 2191 | 1992 |
| Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial G Simonneau, RJ Barst, N Galie, R Naeije, S Rich, RC Bourge, A Keogh, ... American journal of respiratory and critical care medicine 165 (6), 800-804, 2002 | 1856 | 2002 |
| Appetite-suppressant drugs and the risk of primary pulmonary hypertension L Abenhaim, Y Moride, F Brenot, S Rich, J Benichou, X Kurz, ... New England Journal of Medicine 335 (9), 609-616, 1996 | 1599 | 1996 |
| Survival in primary pulmonary hypertension: the impact of epoprostenol therapy VV McLaughlin, A Shillington, S Rich Circulation 106 (12), 1477-1482, 2002 | 1560 | 2002 |
| Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial DB Badesch, VF Tapson, MD McGoon, BH Brundage, LJ Rubin, ... Annals of internal medicine 132 (6), 425-434, 2000 | 1447 | 2000 |
| Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension VV McLaughlin, DE Genthner, MM Panella, S Rich New England Journal of Medicine 338 (5), 273-277, 1998 | 833 | 1998 |
| Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study MJ Budoff, D Georgiou, A Brody, AS Agatston, J Kennedy, C Wolfkiel, ... Circulation 93 (5), 898-904, 1996 | 659 | 1996 |
| Pulmonary arterial hypertension: epidemiology and registries MD McGoon, RL Benza, P Escribano-Subias, X Jiang, DP Miller, ... Journal of the American College of Cardiology 62 (25S), D51-D59, 2013 | 658 | 2013 |
| Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood … GG Pietra, WD Edwards, JM Kay, S Rich, J Kernis, B Schloo, SM Ayres, ... Circulation 80 (5), 1198-1206, 1989 | 621 | 1989 |
| A USA-based registry for pulmonary arterial hypertension: 1982–2006 T Thenappan, SJ Shah, S Rich, M Gomberg-Maitland European Respiratory Journal 30 (6), 1103-1110, 2007 | 580 | 2007 |
| Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults JA Hoff, EV Chomka, AJ Krainik, M Daviglus, S Rich, GT Kondos The American journal of cardiology 87 (12), 1335-1339, 2001 | 534 | 2001 |
| Primary pulmonary hypertension: a vascular biology and translational research “Work in progress” S Archer, S Rich Circulation 102 (22), 2781-2791, 2000 | 527 | 2000 |
| Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation T Thenappan, SJ Shah, S Rich, L Tian, SL Archer, M Gomberg-Maitland European Respiratory Journal 35 (5), 1079-1087, 2010 | 521 | 2010 |
| The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension S Rich, M Seidlitz, E Dodin, D Osimani, D Judd, D Genthner, ... Chest 114 (3), 787-792, 1998 | 518 | 1998 |
| High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right … S Rich, BH Brundage Circulation 76 (1), 135-141, 1987 | 478 | 1987 |
| Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease Myocardial Infarction Genetics Consortium Investigators New England Journal of Medicine 371 (22), 2072-2082, 2014 | 464 | 2014 |
